Profile data is unavailable for this security.
About the company
Hua Medicine is a China-based company principally engaged in the drug development business. The Company is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The Company mainly operates its business in the domestic and overseas markets.
- Revenue in HKD (TTM)82.34m
- Net income in HKD-227.04m
- Incorporated2009
- Employees177.00
- LocationHua MedicineHua Medicine, 275 Ai Di Sheng RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 158869997
- Websitehttps://www.huamedicine.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sunho Biologics Inc | -100.00bn | -100.00bn | 1.05bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -155.25 | -- | -- | -- |
Jacobio Pharmaceuticals Group Co Ltd | 68.27m | -385.99m | 1.16bn | 301.00 | -- | 1.01 | -- | 17.00 | -0.4993 | -0.4993 | 0.0883 | 1.46 | 0.0419 | -- | 5.21 | 226,818.80 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
TOT Biopharm International Co Ltd | 839.03m | -40.58m | 1.45bn | 551.00 | -- | 1.97 | 277.44 | 1.73 | -0.056 | -0.056 | 1.16 | 0.9551 | 0.5808 | 1.87 | 8.03 | 1,522,748.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
CStone Pharmaceuticals | 498.55m | -394.71m | 1.46bn | 230.00 | -- | 2.98 | -- | 2.94 | -0.3129 | -0.3129 | 0.3947 | 0.3824 | 0.2811 | 2.44 | 3.72 | 2,167,590.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Frontage Holdings Corp | 2.03bn | 84.43m | 1.49bn | 1.76k | 17.87 | 0.5549 | 4.11 | 0.732 | 0.0409 | 0.0409 | 0.9808 | 1.32 | 0.463 | 60.63 | 5.32 | 1,154,072.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Wuhan YZY Biopharma Co Ltd | 0.00 | -206.04m | 1.57bn | 123.00 | -- | 11.42 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7078 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
Hua Medicine | 82.34m | -227.04m | 1.59bn | 177.00 | -- | 13.62 | -- | 19.36 | -0.2323 | -0.2323 | 0.0843 | 0.1109 | 0.0538 | 1.69 | 13.03 | 465,208.00 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Mabpharm Ltd | 93.68m | -225.02m | 1.63bn | 347.00 | -- | 7.39 | -- | 17.39 | -0.0546 | -0.0546 | 0.0227 | 0.0534 | 0.0893 | 0.1176 | 6.02 | 269,977.60 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Immunotech Biopharm Ltd | 0.00 | -359.87m | 1.63bn | 211.00 | -- | 8.74 | -- | -- | -0.6993 | -0.6993 | 0.00 | 0.3626 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
Laekna Inc | 0.00 | -396.41m | 1.90bn | 89.00 | -- | 2.20 | -- | -- | -3.28 | -3.28 | 0.00 | 2.22 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
Abbisko Cayman Ltd | 20.49m | -463.87m | 2.25bn | 258.00 | -- | 1.06 | -- | 110.03 | -0.7167 | -0.7167 | 0.0317 | 3.03 | 0.0083 | -- | 1.40 | 79,403.23 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
Alphamab Oncology | 235.14m | -226.35m | 2.28bn | 435.00 | -- | 1.27 | -- | 9.68 | -0.2354 | -0.2354 | 0.245 | 1.86 | 0.1028 | 0.7705 | 19.34 | 540,556.90 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
Data as of Jul 04 2024. Currency figures normalised to Hua Medicine's reporting currency: Hong Kong Dollar HKD
5.85%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Baillie Gifford & Co.as of 31 May 2024 | 25.00m | 2.37% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 14.26m | 1.35% |
Allspring Global Investments LLCas of 31 May 2024 | 9.38m | 0.89% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 5.88m | 0.56% |
CRUX Asset Management Ltd.as of 31 Mar 2023 | 4.07m | 0.39% |
State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 2.32m | 0.22% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 560.00k | 0.05% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 180.00k | 0.02% |
SSgA Funds Management, Inc.as of 06 Jun 2024 | 156.40k | 0.02% |
Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.